STRO
STRO
NASDAQ · Biotechnology

Sutro Biopharma Inc

$15.52
+0.92 (+6.30%)
As of Feb 8, 2:09 PM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 4 25%
Sell 1 6%
Price Target
Analyst Price Target -40.7% upside
Low Target $5.69
Average Target $9.21
High Target $10.08
Current Price $15.52
Current
$15.52
Target
$9.21
$5.69 $9.21 avg $10.08
Scenario Analysis
Bear Case
$5.69
-63.3%
Low target
Base Case
$9.21
-40.7%
Avg target
Bull Case
$10.08
+-35.1%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$10.35
50.0% from high
52-Week Low
$5.54
+180.1% from low
Target vs 52W High
$9.21
-11.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%